Breaking News

Frontera Therapeutics Starts GMP Manufacturing Facility Construction

Designed for clinical manufacturing and initial commercial manufacturing of rAAV gene therapy products.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Frontera Therapeutics held a groundbreaking ceremony to start the construction of its Suzhou facility in bioBAY of Suzhou Industrial Park (SIP), Jiangsu, China. This 4,000-square-meter site will house GMP manufacturing cleanrooms for drug substance and drug product, GMP quality control testing labs, process development pilot plants, and clinical testing labs. This facility is designed for clinical manufacturing and the initial commercial manufacturing of Frontera’s rAAV gene therapy produc...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters